Clinical scenario: rheumatic heart disease | aspirin | inflammatory markers | persistent MR
A 10-year-old boy is diagnosed with acute rheumatic fever with moderate carditis and mitral regurgitation. He is treated with benzathine penicillin and high-dose aspirin (80 mg/kg/day). After 3 weeks of therapy, he is afebrile, joint pain has resolved, and inflammatory markers have normalized. Echocardiography shows persistent moderate mitral regurgitation without worsening.
When is it most appropriate to begin tapering the aspirin dose?
A. As soon as the fever subsides
B. After 1 week of therapy regardless of symptoms
C. After normalization of inflammatory markers and clinical improvement, usually after 2–3 weeks
D. Only after echocardiography shows complete resolution of mitral regurgitation
E. After completion of secondary penicillin prophylaxis
Correct answer & Explanation:
Correct Answer: C. After normalization of inflammatory markers and clinical improvement, usually after 2–3 weeks
Explanation
High-dose aspirin is used to control the inflammatory process in acute rheumatic fever. The dose should not be stopped abruptly.
Once the patient has:
- Clinical improvement (resolution of fever and arthritis),
- Normalization or marked decline of ESR/CRP, and
- Usually 2–3 weeks of treatment have been completed,
the aspirin dose should be gradually tapered over the next 2–3 weeks while monitoring for recurrence of inflammation.
Persistent valvular regurgitation on echocardiography is not an indication to continue high-dose aspirin, as valvular damage may persist despite resolution of active inflammation.
Why the other options are incorrect
- A. As soon as the fever subsides: Fever alone is not sufficient; inflammatory activity should also have resolved.
- B. After 1 week: Too early, as active inflammation often persists.
- D. After complete resolution of mitral regurgitation: Valvular lesions frequently persist and may become chronic despite resolution of inflammation.
- E. After completion of secondary penicillin prophylaxis: Secondary prophylaxis continues for years and is unrelated to the duration of aspirin therapy.
Learning Point
In acute rheumatic fever with carditis:
- High-dose aspirin: Continue until there is clinical improvement and normalization of ESR/CRP, typically after 2–3 weeks.
- Then taper gradually over the following 2–3 weeks.
- Persistent valvular regurgitation does not determine the duration of aspirin therapy.
Reference: American Heart Association Scientific Statement on the Prevention, Diagnosis, and Treatment of Acute Rheumatic Fever (2015); World Health Organization guidance on rheumatic fever and rheumatic heart disease.
